|
🐜
|
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
31 auth.
C. Curtis,
Sohrab P. Shah,
S. Chin,
G. Turashvili,
O. Rueda,
M. Dunning,
D. Speed,
A. Lynch,
S. Samarajiwa,
Yinyin Yuan,
S. Gräf,
G. Ha,
Gholamreza Haffari,
Ali Bashashati,
R. Russell,
...
S. McKinney,
A. Langerød,
A. Green,
E. Provenzano,
G. Wishart,
S. Pinder,
P. Watson,
F. Markowetz,
L. Murphy,
I. Ellis,
A. Purushotham,
A. Børresen-Dale,
J. Brenton,
S. Tavaré,
C. Caldas,
S. Aparicio
|
12 |
2012 |
12
🐜
|
|
🐜
|
The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes
34 auth.
Bernard Pereira,
S. Chin,
O. Rueda,
H. K. Vollan,
E. Provenzano,
H. Bardwell,
Michelle Pugh,
Linda Jones,
R. Russell,
S. Sammut,
D. Tsui,
Bin Liu,
S. Dawson,
J. Abraham,
H. Northen,
...
J. Peden,
A. Mukherjee,
G. Turashvili,
A. Green,
S. McKinney,
A. Oloumi,
Sohrab P. Shah,
N. Rosenfeld,
L. Murphy,
D. Bentley,
I. Ellis,
A. Purushotham,
S. Pinder,
A. Børresen-Dale,
H. Earl,
P. Pharoah,
M. Ross,
S. Aparicio,
C. Caldas
|
10 |
2016 |
10
🐜
|
|
🐜
|
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
17 auth.
A. Wolff,
M. Hammond,
K. Allison,
Brittany E. Harvey,
P. Mangu,
J. Bartlett,
M. Bilous,
I. Ellis,
P. Fitzgibbons,
W. Hanna,
...
R. Jenkins,
M. Press,
P. Spears,
G. Vance,
G. Viale,
L. McShane,
M. Dowsett
|
10 |
2018 |
10
🐜
|
|
🐢
|
Prognostic markers in triple‐negative breast cancer
E. Rakha,
M. E. El-Sayed,
A. Green,
Andrew H. S. Lee,
J. Robertson,
I. Ellis
|
10 |
2007 |
10
🐢
|
|
🐜
|
Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update.
18 auth.
A. Wolff,
M. Elizabeth,
H. Hammond,
K. Allison,
Brittany E. Harvey,
P. Mangu,
J. Bartlett,
M. Bilous,
I. Ellis,
P. Fitzgibbons,
...
W. Hanna,
R. Jenkins,
M. Press,
P. Spears,
G. Vance,
G. Viale,
L. McShane,
M. Dowsett
|
10 |
2018 |
10
🐜
|
|
🐜
|
Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer.
8 auth.
S. Mahmoud,
E. Paish,
D. Powe,
R. Macmillan,
M. Grainge,
Andrew H. S. Lee,
...
I. Ellis,
A. Green
|
10 |
2011 |
10
🐜
|
|
🐜
|
Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies
43 auth.
F. Blows,
K. Driver,
M. Schmidt,
A. Broeks,
F. V. van Leeuwen,
J. Wesseling,
M. Cheang,
K. Gelmon,
T. Nielsen,
C. Blomqvist,
P. Heikkilä,
T. Heikkinen,
H. Nevanlinna,
L. Akslen,
L. Bégin,
...
W. Foulkes,
F. Couch,
Xianshu Wang,
Victoria L. Cafourek,
J. Olson,
L. Baglietto,
G. Giles,
G. Severi,
C. Mclean,
M. Southey,
E. Rakha,
A. Green,
I. Ellis,
M. Sherman,
J. Lissowska,
W. Anderson,
A. Cox,
S. Cross,
M. Reed,
E. Provenzano,
S. Dawson,
A. Dunning,
Manjeet K. Humphreys,
D. Easton,
M. García-Closas,
C. Caldas,
P. Pharoah,
D. Huntsman
|
10 |
2010 |
10
🐜
|
|
🐜
|
MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype
13 auth.
C. Blenkiron,
L. Goldstein,
N. Thorne,
I. Spiteri,
S. Chin,
M. Dunning,
N. Barbosa-Morais,
A. Teschendorff,
A. Green,
I. Ellis,
...
S. Tavaré,
C. Caldas,
E. Miska
|
9 |
2007 |
9
🐜
|
|
🐢
|
Basal-like breast cancer: a critical review.
E. Rakha,
J. Reis-Filho,
I. Ellis
|
9 |
2008 |
9
🐢
|
|
🐢
|
The Nottingham prognostic index in primary breast cancer
M. Galea,
R. Blamey,
C. Elston,
I. Ellis
|
9 |
2005 |
9
🐢
|
|
🐢
|
Breast cancer prognostic classification in the molecular era: the role of histological grade
18 auth.
E. Rakha,
J. Reis-Filho,
F. Baehner,
D. Dabbs,
T. Decker,
V. Eusebi,
S. Fox,
S. Ichihara,
J. Jacquemier,
S. Lakhani,
...
J. Palacios,
A. Richardson,
S. Schnitt,
F. Schmitt,
P. Tan,
G. Tse,
S. Badve,
I. Ellis
|
9 |
2010 |
9
🐢
|
|
🐜
|
Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer.
13 auth.
J. Cuzick,
M. Dowsett,
S. Pineda,
C. Wale,
J. Salter,
E. Quinn,
L. Zabaglo,
E. Mallon,
A. Green,
I. Ellis,
...
A. Howell,
A. Buzdar,
J. Forbes
|
9 |
2011 |
9
🐜
|
|
🐜
|
Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists
19 auth.
S. Badve,
D. Dabbs,
S. Schnitt,
F. Baehner,
T. Decker,
V. Eusebi,
S. Fox,
S. Ichihara,
J. Jacquemier,
S. Lakhani,
...
J. Palacios,
E. Rakha,
A. Richardson,
F. Schmitt,
P. Tan,
G. Tse,
B. Weigelt,
I. Ellis,
J. Reis-Filho
|
9 |
2011 |
9
🐜
|
|
🐜
|
Association between CD8+ T-cell infiltration and breast cancer survival in 12,439 patients.
22 auth.
H. R. Ali,
E. Provenzano,
S. Dawson,
F. Blows,
Bin Liu,
M. Shah,
H. Earl,
C. Poole,
L. Hiller,
J. Dunn,
...
S. Bowden,
C. Twelves,
J. Bartlett,
J. Bartlett,
Sma Mahmoud,
E. Rakha,
I. Ellis,
S. Liu,
D. Gao,
T. Nielsen,
P. Pharoah,
C. Caldas
|
9 |
2014 |
9
🐜
|
